ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 136 filers reported holding ESPERION THERAPEUTICS INC NE in Q4 2021. The put-call ratio across all filers is 1.00 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $294 | -29.5% | 300 | 0.0% | 0.00% | – |
Q2 2023 | $417 | -12.6% | 300 | 0.0% | 0.00% | – |
Q1 2023 | $477 | -74.5% | 300 | 0.0% | 0.00% | – |
Q4 2022 | $1,869 | -6.6% | 300 | 0.0% | 0.00% | – |
Q3 2022 | $2,000 | 0.0% | 300 | 0.0% | 0.00% | – |
Q2 2022 | $2,000 | 0.0% | 300 | 0.0% | 0.00% | – |
Q4 2021 | $2,000 | -66.7% | 300 | 0.0% | 0.00% | – |
Q2 2021 | $6,000 | -25.0% | 300 | 0.0% | 0.00% | -100.0% |
Q1 2021 | $8,000 | 0.0% | 300 | 0.0% | 0.00% | 0.0% |
Q4 2020 | $8,000 | -27.3% | 300 | 0.0% | 0.00% | 0.0% |
Q3 2020 | $11,000 | -26.7% | 300 | 0.0% | 0.00% | 0.0% |
Q2 2020 | $15,000 | +66.7% | 300 | 0.0% | 0.00% | 0.0% |
Q1 2020 | $9,000 | -50.0% | 300 | 0.0% | 0.00% | 0.0% |
Q4 2019 | $18,000 | +63.6% | 300 | 0.0% | 0.00% | 0.0% |
Q3 2019 | $11,000 | -21.4% | 300 | 0.0% | 0.00% | 0.0% |
Q2 2019 | $14,000 | +16.7% | 300 | 0.0% | 0.00% | 0.0% |
Q1 2019 | $12,000 | -14.3% | 300 | 0.0% | 0.00% | 0.0% |
Q4 2018 | $14,000 | +7.7% | 300 | 0.0% | 0.00% | 0.0% |
Q3 2018 | $13,000 | +8.3% | 300 | 0.0% | 0.00% | 0.0% |
Q2 2018 | $12,000 | -45.5% | 300 | 0.0% | 0.00% | -50.0% |
Q1 2018 | $22,000 | +10.0% | 300 | 0.0% | 0.00% | 0.0% |
Q4 2017 | $20,000 | +33.3% | 300 | 0.0% | 0.00% | +100.0% |
Q3 2017 | $15,000 | +7.1% | 300 | 0.0% | 0.00% | 0.0% |
Q2 2017 | $14,000 | +27.3% | 300 | 0.0% | 0.00% | 0.0% |
Q1 2017 | $11,000 | +175.0% | 300 | 0.0% | 0.00% | – |
Q4 2016 | $4,000 | 0.0% | 300 | 0.0% | 0.00% | -100.0% |
Q3 2016 | $4,000 | +33.3% | 300 | 0.0% | 0.00% | – |
Q2 2016 | $3,000 | -40.0% | 300 | 0.0% | 0.00% | -100.0% |
Q1 2016 | $5,000 | -28.6% | 300 | 0.0% | 0.00% | 0.0% |
Q4 2015 | $7,000 | +75.0% | 300 | +100.0% | 0.00% | 0.0% |
Q3 2015 | $4,000 | -50.0% | 150 | +50.0% | 0.00% | 0.0% |
Q2 2015 | $8,000 | – | 100 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Meditor Group Ltd | 2,679,835 | $69,675,000 | 19.39% |
Endurant Capital Management LP | 207,293 | $5,390,000 | 1.94% |
Bellevue Group AG | 5,138,451 | $133,599,000 | 1.53% |
Rhenman & Partners Asset Management AB | 592,225 | $15,398,000 | 1.26% |
PLATINUM INVESTMENT MANAGEMENT LTD | 1,562,869 | $40,635,000 | 0.93% |
JACOB ASSET MANAGEMENT OF NEW YORK LLC | 31,434 | $817,000 | 0.62% |
WASATCH ADVISORS LP | 3,998,010 | $103,949,000 | 0.51% |
HAMILTON LANE ADVISORS LLC | 46,181 | $1,201,000 | 0.45% |
Boxer Capital, LLC | 500,000 | $13,000,000 | 0.42% |
DCF Advisers, LLC | 38,500 | $1,001,000 | 0.41% |